guinea pig |
LD50 |
oral |
1280mg/kg (1280mg/kg) |
? |
Drugs of the Future. Vol. 4, Pg. 140, 1979. |
hamster |
LD50 |
intraperitoneal |
1260mg/kg (1260mg/kg) |
? |
Arzneimittel-Forschung. Drug Research. Vol. 31, Pg. 1816, 1981. |
hamster |
LD50 |
oral |
2400mg/kg (2400mg/kg) |
? |
Arzneimittel-Forschung. Drug Research. Vol. 31, Pg. 1816, 1981. |
mammal (species unspecified) |
LD50 |
oral |
3gm/kg (3000mg/kg) |
? |
Drugs of the Future. Vol. 4, Pg. 140, 1979. |
man |
TDLo |
oral |
1071ug/kg (1.071mg/kg) |
BEHAVIORAL: TREMOR |
Neurology. Vol. 37, Pg. 881, 1987. |
man |
TDLo |
oral |
171mg/kg/6D-I (171mg/kg) |
BEHAVIORAL: MUSCLE WEAKNESS
MUSCULOSKELETAL: OTHER CHANGES |
Israel Journal of Medical Sciences. Vol. 20, Pg. 1082, 1984. |
man |
TDLo |
oral |
4232mg/kg/57W (4232mg/kg) |
BEHAVIORAL: MUSCLE WEAKNESS
BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY)
MUSCULOSKELETAL: OTHER CHANGES |
Japanese Journal of Medicine. Vol. 29, Pg. 545, 1990. |
mouse |
LD50 |
intraperitoneal |
540mg/kg (540mg/kg) |
? |
Arzneimittel-Forschung. Drug Research. Vol. 31, Pg. 1816, 1981. |
mouse |
LD50 |
intravenous |
> 500mg/kg (500mg/kg) |
? |
Drugs in Japan Vol. -, Pg. 341, 1990. |
mouse |
LD50 |
oral |
1220mg/kg (1220mg/kg) |
? |
Chemical and Pharmaceutical Bulletin. Vol. 32, Pg. 1568, 1984. |
mouse |
LD50 |
unreported |
1500mg/kg (1500mg/kg) |
? |
British UK Patent Application. Vol. #2041937, |
rabbit |
LD50 |
oral |
1370mg/kg (1370mg/kg) |
? |
Drugs of the Future. Vol. 4, Pg. 140, 1979. |
rat |
LD50 |
intraperitoneal |
910mg/kg (910mg/kg) |
? |
Journal Europeen de Toxicologie. Vol. 5, Pg. 239, 1972. |
rat |
LD50 |
oral |
940mg/kg (940mg/kg) |
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
BEHAVIORAL: ATAXIA
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" |
Archivos de Farmacologia y Toxicologia. Vol. 6, Pg. 255, 1980. |
rat |
LD50 |
unreported |
1500mg/kg (1500mg/kg) |
? |
United States Patent Document. Vol. #4412998, |
women |
TDLo |
oral |
80mg/kg/2D-I (80mg/kg) |
? |
New England Journal of Medicine. Vol. 301, Pg. 1345, 1979. |